It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Unpack the common reasons budgeting is hard and learn approachable methods to develop healthier financial habits.
24,094 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
JPMorgan warns that a move toward private blockchains could drain liquidity from crypto markets, presenting a fresh h...
Amazon stock is drawing renewed investor attention as AI monetization and AWS growth accelerate. A fresh price predic...
AI-driven demand for high-bandwidth memory is squeezing the global supply, raising costs for devices and testing Appl...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
A cooler June CPI print sparked a risk-on bid in semiconductors, with AMD surging and Intel climbing as investors bet...
Two giants in chip-design software compete for your next tech stock buy. This guide breaks down Cadence Design System...
Two tech giants sit in different lanes: Descartes System Group provides logistics backbone for global trade, while nC...
Two leading midstream ETFs, AMLP and MLPX, battle for income and tax efficiency as the 2026 energy rally persists. Th...
Two popular EM ETFs face off: schwab emerging markets ishares and EEM. This guide breaks down costs, performance, and...
In 2026, two retail powerhouses—Chewy and Walmart—face very different growth paths. This guide dissects their models,...